Surgery Partners, Inc.

For the period ended Dec 31, 2025. Filed Mar 2, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 2, 2026

SGRY$26.73+1.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets - December 31, 202 and

CONSOLIDATED BALANCE SHEETS

(Dollars in millions, except per share amounts)

	December 31,
	2025	2024
ASSETS
Current assets:
Cash and cash equivalents	$239.9	$269.5
Accounts receivable	602.2	579.1
Inventories	96.6	88.4
Prepaid expenses	41.1	36.4
Other current assets	170.9	146.0
Total current assets	1,150.7	1,119.4
Property and equipment, net	1,153.4	1,088.3
Intangible assets, net	41.0	45.7
Goodwill	5,194.6	5,068.0
Investments in and advances to affiliates	234.0	215.4
Right-of-use operating lease assets	289.2	295.7
Other long-term assets	56.8	57.5
Total assets	$8,119.7	$7,890.0
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$208.7	$208.7
Accrued payroll and benefits	64.9	60.4
Other current liabilities	242.6	253.9
Current maturities of long-term debt	99.3	101.4
Total current liabilities	615.5	624.4
Long-term debt, less current maturities	3,602.9	3,268.9
Right-of-use operating lease liabilities	279.9	292.1
Long-term deferred tax liabilities	53.4	39.2
Other long-term liabilities	41.2	30.2
Non-controlling interests—redeemable	395.5	438.8
Stockholders' equity:
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	—	—
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 129,321,144 and 127,109,383, respectively	1.3	1.3
Additional paid-in capital	2,540.6	2,520.9
Accumulated other comprehensive (loss) income	(13.8)	4.8
Retained deficit	(815.2)	(737.3)
Total Surgery Partners, Inc. stockholders' equity	1,712.9	1,789.7
Non-controlling interests—non-redeemable	1,418.4	1,406.7
Total stockholders' equity	3,131.3	3,196.4
Total liabilities and stockholders' equity	$8,119.7	$7,890.0

See notes to unaudited consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.